Effect of survodutide, a glucagon and GLP-1 receptor dual agonist, on weight loss: a meta-analysis of randomized controlled trials
The results of this meta-analysis show that Survodutide is effective in reducing weight, BMI and waist circumference, especially with longer interventions and higher doses.
Authors
- Nathália Sernizon Guimarães (ORCID: https://orcid.org/0000-0002-0487-0500)
- Haijun Wan (ORCID: https://orcid.org/0000-0001-6739-6749)
- Nuo Xu (ORCID: https://orcid.org/0000-0001-7429-701X)
- Somaye Fatahi (ORCID: https://orcid.org/0000-0002-0834-9894)
- Lijuan Wang (ORCID: https://orcid.org/0000-0002-2348-6950)
- Yaping Liu (ORCID: https://orcid.org/0000-0002-2164-2489)
- Mohammad Hassan Sohouli
Institutions
- Universidade Federal de Minas Gerais (BR)
- Nanjing General Hospital of Nanjing Military Command (CN)
- National Nutrition and Food Technology Research Institute (IR)
- Children's Medical Center (IR)
- Shahid Beheshti University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
- Nanjing University (CN)
Publication Details
- Journal
- Diabetology & Metabolic Syndrome
- Published
- 2024-11-06
- DOI
- https://doi.org/10.1186/s13098-024-01501-x
- Citations
- 6
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.15